108 related articles for article (PubMed ID: 26555890)
1. Comparative genomics study for identification of putative drug targets in Salmonella typhi Ty2.
Batool N; Waqar M; Batool S
Gene; 2016 Jan; 576(1 Pt 3):544-59. PubMed ID: 26555890
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomics of Salmonella enterica serovar Typhi strains Ty2 and CT18.
Deng W; Liou SR; Plunkett G; Mayhew GF; Rose DJ; Burland V; Kodoyianni V; Schwartz DC; Blattner FR
J Bacteriol; 2003 Apr; 185(7):2330-7. PubMed ID: 12644504
[TBL] [Abstract][Full Text] [Related]
3. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle Fullerene (C60) demonstrated stable binding with antibacterial potential towards probable targets of drug resistant Salmonella typhi - a computational perspective and in vitro investigation.
Skariyachan S; Parveen A; Garka S
J Biomol Struct Dyn; 2017 Dec; 35(16):3449-3468. PubMed ID: 27817242
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomics of closely related Salmonella enterica serovar Typhi strains reveals genome dynamics and the acquisition of novel pathogenic elements.
Yap KP; Gan HM; Teh CS; Chai LC; Thong KL
BMC Genomics; 2014 Nov; 15(1):1007. PubMed ID: 25412680
[TBL] [Abstract][Full Text] [Related]
6. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
7. Genomic landscape of the emerging XDR Salmonella Typhi for mining druggable targets clpP, hisH, folP and gpmI and screening of novel TCM inhibitors, molecular docking and simulation analyses.
Afzal M; Hassan SS; Sohail S; Camps I; Khan Y; Basharat Z; Karim A; Aurongzeb M; Irfan M; Salman M; Morel CM
BMC Microbiol; 2023 Jan; 23(1):25. PubMed ID: 36681806
[TBL] [Abstract][Full Text] [Related]
8. Chromosome-mediated multidrug resistance in Salmonella enterica serovar Typhi.
Chiou CS; Alam M; Kuo JC; Liu YY; Wang PJ
Antimicrob Agents Chemother; 2015 Jan; 59(1):721-3. PubMed ID: 25367917
[TBL] [Abstract][Full Text] [Related]
9. Genome sequence and comparative pathogenomics analysis of a Salmonella enterica Serovar Typhi strain associated with a typhoid carrier in Malaysia.
Yap KP; Gan HM; Teh CS; Baddam R; Chai LC; Kumar N; Tiruvayipati SA; Ahmed N; Thong KL
J Bacteriol; 2012 Nov; 194(21):5970-1. PubMed ID: 23045488
[TBL] [Abstract][Full Text] [Related]
10. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
[TBL] [Abstract][Full Text] [Related]
11. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
[TBL] [Abstract][Full Text] [Related]
13. An inducible and secreted eukaryote-like serine/threonine kinase of Salmonella enterica serovar Typhi promotes intracellular survival and pathogenesis.
Theeya N; Ta A; Das S; Mandal RS; Chakrabarti O; Chakrabarti S; Ghosh AN; Das S
Infect Immun; 2015 Feb; 83(2):522-33. PubMed ID: 25404028
[TBL] [Abstract][Full Text] [Related]
14. Emergence of Ciprofloxacin-Resistant Salmonella enterica Serovar Typhi in Italy.
García-Fernández A; Gallina S; Owczarek S; Dionisi AM; Benedetti I; Decastelli L; Luzzi I
PLoS One; 2015; 10(6):e0132065. PubMed ID: 26121266
[TBL] [Abstract][Full Text] [Related]
15. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Therapeutic Target against XDR
Jalal K; Khan K; Hassam M; Abbas MN; Uddin R; Khusro A; Sahibzada MUK; Gajdács M
Microorganisms; 2021 Dec; 9(12):. PubMed ID: 34946114
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.
Chuang CH; Su LH; Perera J; Carlos C; Tan BH; Kumarasinghe G; So T; VAN PH; Chongthaleong A; Hsueh PR; Liu JW; Song JH; Chiu CH
Epidemiol Infect; 2009 Feb; 137(2):266-9. PubMed ID: 18474127
[TBL] [Abstract][Full Text] [Related]
19. A chromosomal region surrounding the ompD porin gene marks a genetic difference between Salmonella typhi and the majority of Salmonella serovars.
Santiviago CA; Toro CS; Bucarey SA; Mora GC
Microbiology (Reading); 2001 Jul; 147(Pt 7):1897-1907. PubMed ID: 11429466
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in Bangladesh.
Saha SK; Darmstadt GL; Baqui AH; Crook DW; Islam MN; Islam M; Hossain M; El Arifeen S; Santosham M; Black RE
J Clin Microbiol; 2006 Oct; 44(10):3811-3. PubMed ID: 17021117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
